Vanguard Grant - A pilot trial of heart rate reduction using ivabradine to reduce the microvascular complications of type 2 diabetes mellitus

Project Details

StatusActive
Effective start/end date1/01/1830/06/23

Funding

  • National Heart Foundation of Australia: A$37,808.00
  • National Heart Foundation of Australia: A$37,192.00